ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1169

Downregulated Fli1 in Systemic Sclerosis Myeloid Cells Contributes to Enhanced Transendothelial Migration

Pablo Weilg Espejo1, Taha Dinc2, Fatima El Adili3, Maria Trojanowska4 and Andreea Bujor4, 1Boston Medical Center, Chelsea, MA, 2Boston University School of Medicine, Boston, MA, 3Boston University School of Medicine, Revere, MA, 4Boston University, Boston, MA

Meeting: ACR Convergence 2022

Keywords: Animal Model, macrophages, Monocytes/macrophages, Scleroderma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Systemic Sclerosis and Related Disorders – Basic Science Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: The mononuclear phagocytic system in Systemic Sclerosis (SSc) is central to fibrogenesis and may contribute to fibrosis via enhanced monocyte migration into injured tissues and differentiation of monocytes into profibrotic macrophages. We recently showed that the transcription factor Fli1 is decreased in SSc monocytes, resulting in a profibrotic phenotype, but the effect of decreased Fli1 on monocyte migration is unknown

Methods: To assess the role of Fli1 in monocyte migration, we used siRNA to downregulate Fli1 in THP1 cells and co-cultured them with endothelial cells in transwell inserts. MCP1 (50 ng/ml) was used as a positive control. 24 hours later, the migrated THP1 cells were counted, and results were recorded. GraphPad Prism 7, and one-way ANOVA, followed by Turkey’s multiple comparisons test were used for statistical analysis. Analysis of our previously published microarray dataset (GSE144625) using Ingenuity Pathway Analysis (IPA) and Gene Set Enrichment Analysis (GSEA) was performed to assess changes in monocyte migration in response to Fli1 downregulation. Bleomycin was used to induce lung fibrosis in previously generated mice with myeloid-specific deletion of Fli1 under the LysM promoter (LysMCreFli1fl/fl) and wild-type (WT) mice. Hydroxyproline assay was used to quantify collagen content and IBA1 staining to assess for macrophage infiltration into lung tissue

Results: Downregulation of Fli1 in monocytes via siRNA resulted in enhanced transendothelial migration, both in the absence and presence of MCP1 compared to control, scr-si treated monocytes (4.2×104 vs 2.84×104 and 9.9×104 vs 6.1×104 respectively, P=0.006, Figure 1). Top canonical pathways identified by IPA showed agranulocyte adhesion and diapedesis, leukocyte extravasation signaling, and fibrosis. The GSEA displayed matching results, revealing enrichment of migration-related pathways including regulation of monocyte chemotaxis and positive regulation of leukocyte migration (Figure 2). Amongst the top upregulated genes were MCP1, KITLG, CCL7, CCR7, CCL8, CXCL10, and CXCL11. Analysis of bleomycin-treated mice showed that compared to WT, LysMCreFli1fl/fl mice had significantly higher hydroxyproline content and an increased number of IBA1-positive cells in their lungs in response to bleomycin treatment (Figure 3)

Conclusion: Downregulation of Fli1 in SSc myeloid cells results in enhanced monocyte transendothelial migration, and increased tissue infiltration. Infiltrating macrophages may further attract circulating monocytes via secretion of promigratory chemokines and contribute to exaggerated tissue fibrosis.

Supporting image 1

Figure 1. Transendothelial migration of THP1 cells. Scr-scramble siRNA, Fli1-Fli1 siRNA, HPAECs-human pulmonary arterial endothelial cells. ** p<0.01, * p<0.05

Supporting image 2

Figure 2. 15 significant pathways that were selected among canonical pathways identified by Ingenuity Pathway Analysis

Supporting image 3

Figure 3. Enhanced lung fibrosis and macrophage infiltration in response to bleomycin in mice with myeloid-specific deletion of Fli1. Left: hydroxyproline assay in wt (wild type) and FliCKO (LysMCreFli1fl/fll) mice; n= 3 mice in each group for wt and 4 in each group for LysMCreFli1fl/fll Right: immunohistochemistry for IBA1 in lung tissue.


Disclosures: P. Weilg Espejo, None; T. Dinc, None; F. El Adili, None; M. Trojanowska, None; A. Bujor, None.

To cite this abstract in AMA style:

Weilg Espejo P, Dinc T, El Adili F, Trojanowska M, Bujor A. Downregulated Fli1 in Systemic Sclerosis Myeloid Cells Contributes to Enhanced Transendothelial Migration [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/downregulated-fli1-in-systemic-sclerosis-myeloid-cells-contributes-to-enhanced-transendothelial-migration/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/downregulated-fli1-in-systemic-sclerosis-myeloid-cells-contributes-to-enhanced-transendothelial-migration/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology